CFR Presents

Asia Unbound

CFR experts give their take on the cutting-edge issues emerging in Asia today.

Posts by Category

Showing posts for "Health"

Pakistan Is Failing Its Citizens, and Washington Offers Fighter Jets

by Alyssa Ayres
U.S. President Barack Obama meets Pakistani Prime Minister Nawaz Sharif in the Oval Office of the White House in Washington on October 22, 2015 (Kevin Lamarque/Reuters). U.S. President Barack Obama meets Pakistani Prime Minister Nawaz Sharif in the Oval Office of the White House in Washington on October 22, 2015 (Kevin Lamarque/Reuters).

Pakistani Prime Minister Nawaz Sharif is in Washington for long-awaited consultations with U.S. President Barack Obama. Press reports in the week preceding the visit flagged the possibility of a limited “civil nuclear deal” under discussion as a gambit to persuade Pakistan to stop developing battlefield tactical nuclear weapons, but that conversation ended when Pakistani officials told the media that “Islamabad will not accept limits on its use of small tactical nuclear weapons.” The strategic transaction from the Sharif-Obama meeting now appears, echoing the hoary past, to be another tranche of F16 fighter jets, only the latest in a long cascade of questionable hardware sales with unclear counterterror utility. Read more »

Friday Asia Update: Top Five Stories for the Week of October 9, 2015

by Guest Blogger for Elizabeth C. Economy
Indonesia-fires Residents carry water as they try to extinguish fires near their homes at Pal 7 village in Ogan Ilir district, Indonesia's South Sumatra province, September 3, 2015. (Nova Wahyudi/Reuters)

Rachel Brown, Lincoln Davidson, Sungtae “Jacky” Park, Ayumi Teraoka, and Gabriel Walker look at the top stories in Asia this week.

1. Raging flames in Indonesia. Intense forest fires have been burning for the past few months on the islands of Sumatra and Borneo, blanketing vast areas of Indonesia, Malaysia, Singapore, and southern Thailand with smoke. Annual but illegal slash-and-burn agricultural practices that spiraled out of control caused the blazes, now amounting to more than 1,000 fire clusters on the islands. Read more »

Tu Youyou: An Outlier of China’s Scientific and Technological System

by Yanzhong Huang
Tu Youyou, 84, has become the first Chinese woman to win a Nobel Prize, for her work in helping to create an anti-malaria medicine. (Flickr) Tu Youyou, 84, has become the first Chinese woman to win a Nobel Prize, for her work in helping to create an anti-malaria medicine. (Flickr)

On October 5, a native Chinese scientist, Tu Youyou, won the Nobel Prize in medicine for her role in developing an antimalarial drug that saves millions of lives in Africa and Asia. The award is considered a milestone in China’s history of science and technology as Tu is not only the first Chinese citizen but also the first Chinese-trained scientist ever to be awarded the most prestigious award in science. In fact, unlike other Chinese Nobel laureates in science, all of whom had overseas training, Tu had neither study nor research experience abroad. The most important research that led to the discovery of the medicine for which she was awarded the prize, artemisinin, was conducted in China. Surprised but exalted, many Chinese have attributed this prize to China’s scientific and technological (S&T) regime. Already, social media in China is flooded with discussions on who will be the next Chinese scientist to win the prize. Read more »

The UN Sustainable Development Goals: An Opportunity for Niche Diplomacy by Middle-Power Korea

by Guest Blogger for Scott A. Snyder
South Korea's President Park Geun-hye addresses the 69th United Nations General Assembly at U.N. headquarters in New York, September 24, 2014. (Mike Segar/Reuters) South Korea's President Park Geun-hye addresses the 69th United Nations General Assembly at U.N. headquarters in New York, September 24, 2014. (Mike Segar/Reuters)

Brendan Howe is a professor at Ewha Womans University’s Graduate School of International Studies.

From September 25 to 27, South Korean President Park Geun-hye will be attending the United Nations (UN) Development Summit in New York, where she will be giving the keynote address. Much of the summit will focus on the so-called Sustainable Development Goals (SDG). The SDGs are a set of proposals that look to build on two high profile international governance agendas: [1] international development cooperation, dominated since 2000 by the eight Millennium Development Goals (MDGs) set to expire at the end of 2015; and [2] twenty years of environmental cooperation since the landmark United Nations Conference on Environment and Development (UNCED). Read more »

Does MERS Pose a Serious Threat to China?

by Yanzhong Huang
A health worker with protective suits sitting with people who came into close contact with the Korean MERS patient arrive at Lady MacLehose Holiday Village in Sai Kung, where they will spend two weeks in quarantine, in Hong Kong, China May 30, 2015. China said on Friday a 44-year-old South Korean man had tested positive for Middle East Respiratory Syndrome (MERS), China's first confirmed case, but that it had not found any symptoms in 38 people who had been in close contact with him. (Reuters/Tyrone Siu) A health worker with protective suits sitting with people who came into close contact with the Korean MERS patient arrive at Lady MacLehose Holiday Village in Sai Kung, where they will spend two weeks in quarantine, in Hong Kong, China May 30, 2015. China said on Friday a 44-year-old South Korean man had tested positive for Middle East Respiratory Syndrome (MERS), China's first confirmed case, but that it had not found any symptoms in 38 people who had been in close contact with him. (Reuters/Tyrone Siu)

Last Friday, China confirmed its first case of Middle East Respiratory Syndrome (MERS) in Guangdong province. The now-confirmed South Korean MERS patient, who ignored travel warnings and lied about his conditions when flying to China, had been in close contact with seventy-seven people in the province. As of June 1, sixty-four have been quarantined while the thirteen others remain to be found. Read more »

Podcast: China’s Environmental Health Crisis – Challenges and Politics

by Yanzhong Huang
Women wear face masks on the Bund in front of the Oriental Pearl TV Tower during a hazy day in downtown Shanghai January 26, 2015. (Aly Song/Courtesy Reuters) Women wear face masks on the Bund in front of the Oriental Pearl TV Tower during a hazy day in downtown Shanghai January 26, 2015. (Aly Song/Courtesy Reuters)

After more than three decades of rapid industrialization and modernization, China is on the cusp of potentially becoming the world’s largest economy. Yet China’s economic miracle has imposed tremendous costs on the environment and public health. Topping this list is extensive air pollution, water pollution, and soil contamination—outdoor air pollution, for example, has been linked to 1.2 million premature deaths in China. The result, as shown in the recent viral documentary “Under the Dome,” has been an environmental health crisis that has profound economic, social, and political ramifications. The ascending popularity of the documentary, followed by its quick disappearance from all major websites in China, beget a series of questions on China’s environmental health crisis: What is the nature and magnitude of the crisis? What are its causes and consequences?  What is the response of the Chinese government to the crisis and is this response sufficient to the challenges at hand? Read more »

Rotenberg and Di: Ali Health Offers a Revolutionary Moment for China’s Healthcare Industry

by Guest Blogger for Yanzhong Huang
Alibaba Group Holding Ltd chairman Jack Ma gestures during a talk by Our Hong Kong Foundation in Hong Kong, February 2, 2015. The head of China's commerce regulator met with Alibaba Group Holding Ltd chairman Jack Ma last Friday to discuss combating fake products, the official Xinhua news agency reported, with the two adopting a conciliatory tone after a row over illegal business on the Internet company's platforms. (Bobby Yip/Courtesy Reuters) Alibaba Group Holding Ltd chairman Jack Ma gestures during a talk by Our Hong Kong Foundation in Hong Kong, February 2, 2015. The head of China's commerce regulator met with Alibaba Group Holding Ltd chairman Jack Ma last Friday to discuss combating fake products, the official Xinhua news agency reported, with the two adopting a conciliatory tone after a row over illegal business on the Internet company's platforms. (Bobby Yip/Courtesy Reuters)

Ariella Rotenberg is a research associate for U.S. Foreign Policy, and Peng Di is an intern for Global Health Governance at the Council on Foreign Relations.

Private sector actors in China, first and foremost Alibaba, are taking significant steps to do what they believe will earn a handsome profit in the growing Chinese healthcare industry. With a market estimated to reach one trillion dollars by 2020, companies are working fast to secure their slice of the expanding Chinese healthcare pie. Read more »

Artemisinin’s Rocky Road to Globalization: Part III

by Yanzhong Huang
A Ministry of Public Health official holds blood test slides taken from children, who live in the Thai-Myanmar border, at a malaria clinic in the Sai Yoke district, Kanchanaburi Province October 26, 2012. Globally, 3.3 billion people are at risk of malaria infection. While Africa has the highest malaria burden, most the 46,000 deaths outside Africa occurred in Asia Pacific. There are also concerns over a growing parasite resistance. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Sukree Sukplang/Courtesy: Reuters) A Ministry of Public Health official holds blood test slides taken from children, who live in the Thai-Myanmar border, at a malaria clinic in the Sai Yoke district, Kanchanaburi Province October 26, 2012. Globally, 3.3 billion people are at risk of malaria infection. While Africa has the highest malaria burden, most the 46,000 deaths outside Africa occurred in Asia Pacific. There are also concerns over a growing parasite resistance. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Sukree Sukplang/Courtesy: Reuters)

In the previous blog post, I discussed how China’s efforts to promote its artemisinin-based drugs in the global market have ended up placing their pharmaceutical firms at the lower end of the supply chain. Not all Chinese pharmaceutical companies were content with this arrangement. In 1994, Beijing Holley-Cotec became the first Chinese manufacturer to export dihydroartemisinin (“Cotecxin”), one of the artemisinin derivatives that the company developed with an original Chinese brand. Read more »

Artemisinin’s Rocky Road to Globalization: Part II

by Yanzhong Huang
A health worker checks a blood sample for malaria in the only hospital in Pailin in western Cambodia January 28, 2010. Bordering with Thailand, this former Khmer Rouge stronghold and dusty gem mining town is now better known for a malarial parasite that is worrying health experts in the region. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Damir Sagolj/ Courtesy: Reuters) A health worker checks a blood sample for malaria in the only hospital in Pailin in western Cambodia January 28, 2010. Bordering with Thailand, this former Khmer Rouge stronghold and dusty gem mining town is now better known for a malarial parasite that is worrying health experts in the region. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. (Damir Sagolj/ Courtesy: Reuters)

In my previous blog post, I described how artemisinin-based drugs were discovered in China in the 1970s and 1980s. Given their potency for the treatment of malaria, one would expect that Chinese made artemisinin-based drugs quickly became the first choice medicine in the global fight against malaria. Much to the chagrin of Chinese scientists and pharmaceutical companies, the World Health Organization (WHO) did not list a single one of China’s antimalarial drugs on its procurement list until 2007.

Read more »

Artemisinin’s Rocky Road to Globalization: Part I

by Yanzhong Huang
A Thai Public Heath Ministry official places a thermometer into a child's mouth at a malaria clinic in Sai Yoke district, Kanchanaburi Province October 26,2012. The child, who lives on the Thai-Myanmar border, came to the clinic to get tested for malaria. Globally, 3.3 billion people are at risk of malaria infection. While Africa has the highest malaria burden, most the 46,000 deaths outside Africa occurred in Asia Pacific. There are also concerns over a growing parasite resistance. Studies and research show artemisinin-based therapies - currently the most effective treatment against malaria - are taking longer to cure some of the patients. REUTERS/Sukree Sukplang (THAILAND - Tags: POLITICS HEALTH) A Thai Public Heath Ministry official places a thermometer into a child's mouth at a malaria clinic in Sai Yoke district, Kanchanaburi Province, on October 26, 2012 (Sukree Sukplang/Courtesy of Reuters).

Artemisinin, or Qinghaosu, is isolated from Artemisia annua L., a plant native to China but now naturalized in many other countries. Today, the artemisinin group of drugs is considered the most efficacious and fast-acting antimalarial known to the humankind. In 2011, Dr. Tu Youyou, a Chinese medical scientist, won the Lasker Award in Clinical Medicine—one of the most respected science prizes in the world—for discovering the antimalarial treatment that has saved millions of lives worldwide, especially in the developing countries. Read more »